lecanemab (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Alzheimer Disease

Pending FDA approval for treatment of mild cognitive impairment owing to Alzheimer disease

Next:

Pharmacology

Mechanism of Action

Anti-amyloid beta (Aβ) protofibril antibody; binds to Aβ protofibrils, prior to when the fibrils nucleate into plaques

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.